CME's Duffy: Regulatory Uncertainty Weighing On Share Price

A protracted process for designing and implementing new rules for trading financial derivatives continues to weigh on the share price of CME Group Inc. (CME), according to the exchange company's executive chairman.

An uncertain outcome for the sweeping changes aimed at the market has clouded CME's otherwise strong performance, and CME shares have underperformed the broader market, CME's Terry Duffy told investors Wednesday.

"Like the rest of you, I am frustrated with this," Duffy said at CME's annual shareholder meeting.

Duffy said CME has invested heavily in growth projects that will serve the company well as new rules and trading practices come into focus.

A new clearing unit launched last month in London that currently handles trades in off-exchange energy markets will expand to include additional over-the-counter products, as well as exchange-listed contracts, he said.

-By Jacob Bunge, Dow Jones Newswires; 312 750 4117; jacob.bunge@dowjones.com

CME (NASDAQ:CME)
Historical Stock Chart
From May 2024 to Jun 2024